← Back to Search

White Button Mushroom Extract for Breast Cancer Risk Reduction

N/A
Recruiting
Led By Lisa D Yee
Research Sponsored by City of Hope Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Have a known genetic mutation associated with hereditary breast cancer (including BRCA1, BRCA2, p53, etc.)
Two or more second degree relatives with breast cancer, with at least one under the age of 50
Must not have
History of a bleeding tendency or current use of Coumadin or other anticoagulants
Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, hypertension, or psychiatric illness/social situation that would limit compliance with study requirements
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 3 months
Awards & highlights

Summary

This trial is testing if eating white button mushrooms every day can help improve health in obese postmenopausal women at high risk of breast cancer. The mushrooms might help by making immune cells work better and reducing long-term inflammation. Researchers hope this could lower the risk of breast cancer and improve overall health.

Who is the study for?
This trial is for postmenopausal women with a high BMI (>=30 kg/m^2), at increased risk of breast cancer due to factors like genetic mutations (BRCA1/2, p53), family history, or previous diagnoses of certain breast conditions. Participants must be over 21 years old, have had no recent mushroom supplements, and not be on hormone therapies or other treatments that could interfere.
What is being tested?
Researchers are testing the effects of white button mushroom extract on inflammation and immune function in obese postmenopausal women at high risk for breast cancer. The study involves taking the supplement and monitoring changes through questionnaires and blood tests to see if it might reduce body fat or cancer risk.
What are the potential side effects?
While specific side effects aren't listed for white button mushroom extract in this context, potential risks may include allergic reactions or digestive issues given its nature as a dietary supplement. Participants with known sensitivities to similar compounds are excluded from the trial.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have a genetic mutation linked to breast cancer.
Select...
Two or more of my relatives have had breast cancer, with one being younger than 50.
Select...
I am postmenopausal.
Select...
I am a postmenopausal woman with a BMI of 30 or higher and at high risk for breast cancer.
Select...
I am fully active or restricted in physically strenuous activity but can do light work.
Select...
My risk of developing breast cancer is high based on the Gail Risk Assessment.
Select...
I had a biopsy showing early breast changes in the last 10 years.
Select...
I have a family member with breast cancer diagnosed before 60.
Select...
I can swallow pills.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have a history of bleeding easily or am currently using blood thinners.
Select...
I do not have any serious illnesses or social situations that would stop me from following the study's requirements.
Select...
I haven't taken hormone-modifying meds like HRT, SERMs, AIs, or GnRH modifiers in the last 3 months.
Select...
I am currently receiving treatment for cancer.
Select...
I haven't taken any mushroom supplements in the last 3 months.
Select...
I regularly take full dose aspirin or NSAIDs.
Select...
I have not gone through menopause.
Select...
I am currently taking medication that suppresses my immune system.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 3 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Relative change in immune cell composition within the peripheral blood mononuclear (PBMC) compartment
Relative change in levels of circulating myeloid-derived suppressor cells (MDSCs) within the peripheral blood mononuclear (PBMC) compartment
Secondary study objectives
Incidence of adverse events
Relative change in inflammatory cytokine gene expression in PBMC compartment

Trial Design

1Treatment groups
Experimental Treatment
Group I: Prevention (white button mushroom)Experimental Treatment2 Interventions
Participants receive white button mushroom PO daily for 3 months in the absence of disease progression or unacceptable toxicity.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for breast cancer include chemotherapy, hormone therapy, and immunotherapy, each with distinct mechanisms of action. Chemotherapy targets rapidly dividing cancer cells, causing cell death but also affecting normal cells, leading to side effects. Hormone therapy blocks hormones like estrogen that fuel certain breast cancers, slowing or stopping tumor growth. Immunotherapy enhances the body's immune response against cancer cells, often by targeting specific proteins that inhibit immune activity. These treatments are crucial for breast cancer patients as they aim to reduce tumor size, prevent metastasis, and improve survival rates. The anti-inflammatory and immunomodulatory effects, similar to those studied with White Button Mushroom, are particularly important as they can potentially reduce side effects and enhance the body's natural defenses against cancer.

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,842 Previous Clinical Trials
41,002,974 Total Patients Enrolled
945 Trials studying Breast Cancer
1,543,964 Patients Enrolled for Breast Cancer
City of Hope Medical CenterLead Sponsor
596 Previous Clinical Trials
1,923,511 Total Patients Enrolled
43 Trials studying Breast Cancer
6,649 Patients Enrolled for Breast Cancer
Lisa D YeePrincipal InvestigatorCity of Hope Medical Center
1 Previous Clinical Trials
36 Total Patients Enrolled

Media Library

White Button Mushroom Extract Clinical Trial Eligibility Overview. Trial Name: NCT04913064 — N/A
Breast Cancer Research Study Groups: Prevention (white button mushroom)
Breast Cancer Clinical Trial 2023: White Button Mushroom Extract Highlights & Side Effects. Trial Name: NCT04913064 — N/A
White Button Mushroom Extract 2023 Treatment Timeline for Medical Study. Trial Name: NCT04913064 — N/A
~1 spots leftby Dec 2024